For the twelve months ended Sep 30, 2026, Amrize Ltd reported $12.26B of revenue and $1.25B of net income.
AMRZ revenueQ3 2026$3.77B
- Quarter YoY
- +2.2%
- QoQ
- +7.9%
- FY YoY
- +0.9%
AMRZ revenue was $3.77B in fiscal Q3 2026 (ended Sep 30, 2026), up 2.2% from a year earlier and up 7.9% from the prior quarter. For the full fiscal 2025 it was $11.81B, up 0.9% from fiscal 2024.
AMRZ net incomeQ3 2026$559.00M
- Quarter YoY
- +3.1%
- QoQ
- +16.9%
- FY YoY
- -7.0%
AMRZ net income was $559.00M in fiscal Q3 2026 (ended Sep 30, 2026), up 3.1% from a year earlier and up 16.9% from the prior quarter. For the full fiscal 2025 it was $1.19B, down 7.0% from fiscal 2024.
AMRZ EPSQ3 2026$1.02
- Quarter YoY
- +4.1%
- QoQ
- +18.6%
- FY YoY
- -7.0%
AMRZ diluted EPS was $1.02 in fiscal Q3 2026 (ended Sep 30, 2026), up 4.1% from a year earlier and up 18.6% from the prior quarter. For the full fiscal 2025 it was $2.14, down 7.0% from fiscal 2024.
AMRZ free cash flowQ3 2026$431.00M
- Quarter YoY
- -35.6%
- QoQ
- +149.1%
- FY YoY
- -13.4%
AMRZ free cash flow was $431.00M in fiscal Q3 2026 (ended Sep 30, 2026), down 35.6% from a year earlier and up 149.1% from the prior quarter. For the full fiscal 2025 it was $1.42B, down 13.4% from fiscal 2024.
Source: XBRL data Amrize Ltd files with the SEC, latest filing dated Oct 29, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.
Per-share figures are as filed. The filings show no stock split in these periods.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.